1.Effect of Ultrasound Transdermal Drug Delivery Combining with Semiconductor Laser on Chronic Pelvic Inflammation Disease
Chinese Journal of Rehabilitation Theory and Practice 2006;12(5):425-426
ObjectiveTo study the effect of ultrasound transdermal drug delivery combining with semiconductor laser on chronic pelvic inflammation disease(CPID).Methods80 CPID patients were divided into two groups randomly: 40 cases for treating group who accepted ultrasound transdermal drug delivery and semiconductor laser. 40 cases for the control group who accepted ultrasound transdermal drug delivery only. After 30 days of treating, a Condition-Score was assessed. ResultsIn the treating group, 18 cured, 19 remarkable effective, 3 effective, which was significant improved compared with that in the control group, 6 cases cured, 21 cases remarkably effect,10 cases effective, 3 case ineffective(P<0.01).ConclusionUltrasound transdermal drug delivery combined with semiconductor laser is more effective on chronic pelvic inflammation disease.
2.Innovating the Method of Pharmaceutical Education by Following its Developing Trend
Chinese Journal of Medical Education Research 2006;0(12):-
This thesis discusses the innovation of pharmaceutical education by analyzing its new trends.The author also puts forward some methods to accelerate the innovation in pharmaceutical education.
3.Predictive factors of gestational diabetes mellitus
Journal of Medical Postgraduates 2003;0(07):-
Gestational diabetes mellitus is detrimental to the health of both the mother and the fetus,and therefore greater attention is being paid to the earlier diagnosis and treatment of the condition.This article offers an overview of the research progress in the predictive factors of gestational diabetes mellitus.
4.Etiological factors of fetal macrosomia
Journal of Medical Postgraduates 2003;0(08):-
The infant with macrosomia has been the focus of attention and controversy for some time, and fetal macrosomia affects neonatal and maternal morbidity and mortality. This review summarized the etiological factors of fetal macrosomia.
5.Advancement in diagnosis and treatment of acute retinal necrosis syndrome
International Eye Science 2017;17(7):1261-1264
Acute retinal necrosis syndrome (ARNS) is a group of eye syndrome.Acute uveitis, retinal artery occlusive vasculitis, fused necrotic retinitis and late stage of retinal detachment is the main clinical manifestation.A part of patients may be associated with increased intraocular pressure.The etiology and pathogenesis is still not clear completely and most people think that may be related to the virus infection, which mainly to reflected to be herpes simplex virus (HSV), varicella zoster virus (VZV), EB virus and giant cell virus (CMV) infection.Its diagnosis mainly depends on clinical manifestation, examination and etiological examination.Acute retinal necrosis syndrome is urgent and develops quickly, and it is lack of specific clinical symptoms in early times.By the way, it enjoys high misdiagnosis rate and poor prognosis.It is hard to cure, therefore, it is an important reason for the blindness.Once diagnosed, treatment should be adopted by carrying local and systemic antiviral, preventive laser photocoagulation in time.At the same time, it is essential that vitreous body resection combine with silicone oil tamponade treatment when necessary.The study shows that the effective measures of early treatment will be able to prevent disease progression and improve visual acuity.Therefore, early diagnosis and treatment of acute retinal necrosis syndrome is very important.In this paper, combination of the literature on the diagnosis and treatment of acute retinal necrosis syndrome were reviewed.
7.Aralysis of related factors of anemia in elderly patients with heart failure
Changming WU ; Qun CHEN ; Shangzhi XU
Chinese Journal of Primary Medicine and Pharmacy 2011;18(23):3213-3214
Objective To analyze anemia in patients with chronic heart failure changes in relevant indicators.Methods 48 chronic heart failure patients(observation group)and 48 healthy people(control group).were erolled the peripheral blood red blood cell count(RBC),hemoglobin(Hb),hematocrit(Hct)and other anemia-related indicators were measured.Results The results of the observation group RBC,Hb,Hct,were(3.37 ±0.49)× 1012/L,(103.64±14.33)g/L,(0.31 ±0.08)respectively,the control group were(4.64 ±0.51)× 1012/L,(121.33 ±17.69)g/L,(0.37 ± 0.07),between the two groups were statistically significant(t =4.46、3.06、4.18,P =0.02,0.04,0.04);treatment,symptoms of heart failure in observation group mitigation,RBC is(3.76 ± 0.58)× 1012/L,compared with the control group the difference was significant(t =0.48,P =0.03); observation group Hb,Hct were (123.77 ± 17.26)g/L,(0.37 ± 0.05),and were not significantly different with the amtrol gronp(P =0.06,0.11).Conclusion Elderly patients with anemia associated with heart failure were lower than healthy people,heart failure and anemia had,a significant correlation with aremia.
8.Study of the influence of Yifei-Kangxin capsule on MMP-1 of rats model with pulmonary heart disease
Qun LIANG ; Xicheng JIANG ; Haikun WU
International Journal of Traditional Chinese Medicine 2011;33(6):508-510
Objective To discuss the influence of Yifei-Kangxin capsule on MMP-1 in Wistar rats model with pulmonary heart disease. Methods 40 Wistar rats with pulmonary heart disease were averagely grouped as Normal Group, Model Group, Therapeutic Group and Comparative Group randomly by weight. The rats in Therapeutic Group were given Yifei-Kangxin capsule and the rats in Comparative Group were given Nifedipine. The course of treatment was 15 days. The rats were killed at the next 7th, 14th and 28th day separately to test MMP-1 in pulmonary tissue. Results After the treatment, the expression of MMP-1 in pulmonary tissue of the Therapeutic Group[7 d, 14 d, 28 d was(0.231±0.017)ng/m、(0.308±0.081)ng/m、(0.358±0.074)ng/m]was lower than the Model Group[7 d, 14 d, 28 d was(0.266±0.036)ng/m 、(0.315± 0.060)ng/m、(0.612±0.091)ng/m]. Conclusion Yifei-Kangxin capsule can inhibit the expression of MMP-1 in the rats model pulmonary heart disease.
9.Clinical Observation of Bu Shen Tiao Qi Needling for Perimenopausal Syndrome
Guirong XIAO ; Kaiyang WANG ; Qun WU
Shanghai Journal of Acupuncture and Moxibustion 2017;36(2):157-161
Objective To observe the clinical efficacy of Bu Shen Tiao Qi(supplementing the kidney and regulating qi) needling in treating perimenopausal syndrome.Method Fifty patients were randomized into two groups, 25 cases each. The treatment group was intervened by Bu Shen Tiao Qineedling combined with electroacupuncture, while the control group was by shallow needling plus sham electroacupuncture. Kupperman Index (KI) wasobserved respectively before treatment, after 2-week and 4-week treatment, and in the 4-week follow-up study. The differences of scores and improvements of the 13 symptoms listed in KI were calculated.Result The total effective rate was 92.0% in the treatment group versus 44.0% in the control group; in the treatment group, the KI scores after 2-week treatment and in the 4-week follow-up study were significantly different from that before treatment (P<0.05), and a more significant difference was found after 4-week treatment (P<0.01); the between-group differences were statistically significant in comparing KI (P<0.05).Conclusion Bu Shen Tiao Qineedling can produce a satisfactory efficacy in treating perimenopausal syndrome.
10.Case report of rare xeroderma pigmentosum and growth hormone deficiency
Lingli LI ; Qun LIAN ; Jinzhun WU
Chinese Journal of Applied Clinical Pediatrics 2016;31(19):1502-1503
@@